Search

The COVID-19 pandemic is having a detrimental impact on substance use, mental health, and weight-related health behaviors among people with obesity, according to a new study by researchers at UT Southwestern and the UTHealth School of Public Health.

Artificial intelligence is rapidly reshaping the landscape of health care, revolutionizing scientific discovery, drug development, diagnosis and treatment, as well as health care delivery operations. As with any emerging technology, its success lies in its implementation, and The University of Texas

Colorectal surgeon who led Johns Hopkins physician practice to focus on integration of clinical, research, education missions at UTSW

Activating specific neurons in a part of the brain that serves as the body’s master circadian pacemaker caused mice to eat significantly more during a time of day when they would normally be at rest, a UT Southwestern Medical Center study shows.

Overweight and obesity patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs were more likely to stick with their treatment longer than those who didn’t switch, according to a new study by UT Southwestern Medical Center researchers.

The world’s top competitors in the 2026 Olympics, which continue through Feb. 22, may offer a valuable lesson to those seeking to improve their workouts or just to get more active. While these elite athletes are performing at a peak level on a global stage, it’s the work they put in behind the

Being younger doesn’t protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern.

Protein complexes that play a critical role in launching an immune response assemble in droplets that form within the liquid environment in cells much like oil droplets in water, UT Southwestern scientists report in a new study.

With NASA preparing to send humans to Mars in the 2030s, researchers are studying the physical effects of spending long periods in space.

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.